Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Tufi

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cell Reports|May 3, 2019
Comprehensive Genetic Characterization of Mitochondrial Ca<sup>2+</sup> Uniporter Components Reveals Their Different Physiological Requirements In VivoRoberta Tufi, Thomas P Gleeson, Sophia von Stockum, et al.
Cell Reports|January 18, 2024
Partial loss of MCU mitigates pathology in vivo across a diverse range of neurodegenerative disease modelsMadeleine J Twyning, Roberta Tufi, Thomas P Gleeson, et al.
Immunological Reviews|November 6, 2007
Ecto-calreticulin in immunogenic chemotherapyMichel Obeid, Antoine Tesniere, Theocharis Panaretakis, et al.
Nature Cell Biology|January 21, 2014
Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's diseaseRoberta Tufi, Sonia Gandhi, Inês P de Castro, et al.
Nature Communications|July 25, 2019
Mitochondrially-targeted APOBEC1 is a potent mtDNA mutator affecting mitochondrial function and organismal fitness in DrosophilaSimonetta Andreazza, Colby L Samstag, Alvaro Sanchez-Martinez, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cell Reports|May 3, 2019
Comprehensive Genetic Characterization of Mitochondrial Ca<sup>2+</sup> Uniporter Components Reveals Their Different Physiological Requirements In VivoRoberta Tufi, Thomas P Gleeson, Sophia von Stockum, et al.
Cell Reports|January 18, 2024
Partial loss of MCU mitigates pathology in vivo across a diverse range of neurodegenerative disease modelsMadeleine J Twyning, Roberta Tufi, Thomas P Gleeson, et al.
Immunological Reviews|November 6, 2007
Ecto-calreticulin in immunogenic chemotherapyMichel Obeid, Antoine Tesniere, Theocharis Panaretakis, et al.
Nature Cell Biology|January 21, 2014
Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's diseaseRoberta Tufi, Sonia Gandhi, Inês P de Castro, et al.
Nature Communications|July 25, 2019
Mitochondrially-targeted APOBEC1 is a potent mtDNA mutator affecting mitochondrial function and organismal fitness in DrosophilaSimonetta Andreazza, Colby L Samstag, Alvaro Sanchez-Martinez, et al.
Pageof 2